On November 15 2021, ALS Texas was joined by Neurologists and Clinic Directors, Dr. Jeffrey Tramonte and Dr. Stanley...
Research Articles

New Research Update for Proposed ALS Drug Treatment — AMX0035
We’re excited to share another milestone in the search for better drug treatments for ALS. Amylyx announced today that...
Advancing Research: The HEALEY ALS Platform Trial
In 2020, the ALS Association, in partnership with Massachusetts General Hospital, launched an innovative approach to...
ALS Association Continues to Put Pressure on the FDA
One month ago on May 25, 2021, representatives from the FDA joined a We Can’t Wait Action Meeting. During this...
We Can’t Wait: ALS Advocates Urge the FDA to Expedite Access to Experimental Therapies
The average life expectancy for someone after an ALS diagnosis is only 2 – 5 years. However, the process of...
Because of You: 2020 in Review
This year our ALS community has come together in new ways, connecting from afar and working together, even when we are...
ALS Drug Shows Further Promise, Slowing Progression and Increasing Survivability
Muscle and Nerve has published the results of the open label extension study of AMX0035, a promising new drug therapy...
ALS Drug Slows Progression, Petition for FDA Approval
The New England Journal of Medicine (NEJM) has published the results of a phase 2 trial (known as CENTAUR) of the...
ALS Association Makes Multi-Year Commitment to HEALEY ALS Platform Trial
This week a $3 million commitment was made by The ALS Association to the first platform trial for ALS. The platform...
Clinical Trials Give Hope to Texans with ALS
The ALS Association of Texas invests in research to discover effective treatments and a cure for ALS. One of the ways...
ALS Association Awards Joint Grant to Help Fund Houston Neurologist’s Groundbreaking Research
The ALS Association, ALS Finding a Cure (ALSFAC), and MDA have jointly awarded a $2.5 million clinical trial grant to...
Houston Neurologist Discovers Treatment That Could Halt the Progression of ALS
Dr. Stanley Appel, neurologist and co-director of the Houston Methodist Hospital Neurology Institute, has been leading...